UNSPSC 51182102: Argipressin or vasopressin

This classification denotes antidiuretic hormones released by the neurohypophysis of all vertebrates (structure varies with species) to regulate water balance and osmolarity, most especially arginine vasopressin, which typically arises in the molecular formula C46H65N15O12S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Y87Y826H08, chemically known as 1-[19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[1-[(2-amino-2-oxoethyl)amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]pyrrolidine-2-carboxamide but generally known as vasopressin, which bears US NIH Compound Identifier 8230.

UNSPSC 51182102 Argipressin or vasopressin is a Commodity code for a specific pharmaceutical agent used in state and local government healthcare and emergency medical settings. State and local procurement bodies — primarily public health departments, county hospitals, emergency medical services, and correctional health systems — source this drug for acute medical care, particularly in the treatment of variceal bleeding, septic shock, and cardiac arrest scenarios where vasopressor support is critical. The solicitations under this code reflect procurement of the pharmaceutical itself, typically in injectable form, rather than related equipment or services.

No recent state and local contract opportunities matching this Commodity code appear in the source data. The code sees limited procurement activity in the public sector compared to broader pharmaceutical or emergency medical supply categories, reflecting the specialized clinical indications and relatively low-volume demand for this particular agent outside hospital pharmacy systems and emergency response protocols.